Dan Reznikov is the Society’s Chief Financial Officer. Prior to joining the Society, Dan served as Chief Financial Officer at the global biotech nonprofit, Aeras, an organization focused on developing tuberculosis vaccines. For over 30 years, Dan has held senior leadership roles focused in finance, operations, and administration at organizations such as the University of Maryland Biotechnology Institute (UMBI), the ALS Association, and the American Type Culture Collection (ATCC) and the Howard Hughes Medical Institute (HHMI). He began his career in public accounting and at a large manufacturing and aerospace defense corporation. He received a B.S. in Accounting from the University of Maryland-College Park, and his M.B.A., with a focus on Finance & Investments, from George Washington University. In addition, Dan is a CPA.